Arbutus to Participate in October Investor Conferences

Arbutus Biopharma

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced that the Company will participate in the following October investor conferences:

Chardan’s 5th Annual Genetic Medicines Conference – Virtual (October 4-5, 2021)

  • Fireside Chat: Tuesday, October 5, 2021 at 4:30 pm ET
  • Presenters: William Collier, President and Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial Officer

H.C. Wainwright Hepatitis B Virus (HBV) Virtual Conference (October 13, 2021)

  • Fireside Chat: Wednesday, October 13, 2021 at 1:00 pm ET
  • Presenters: William Collier, Dr. Michael Sofia, Dr. Gaston Picchio, and David Hastings

The Company states that live webcast links for the fireside chats can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. An archived replay of the webcast will be available on the Company’s website after the conference.

READ:  Windtree Hosting Key Opinion Leader Webinar on Istaroxime

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.